Divi's Lab

In Q3FY23, Divi's Lab reported a 66 per cent year-on-year decline in its consolidated net profit at Rs 306.80 crore, on higher than expected in fall in revenue

CLOSING BELL: The Nifty PSU Bank index sharply outperformed other indices as it gained 4.5 per cent

Divi's Laboratories on Monday said its consolidated net profit increased by 78 per cent to Rs 895 crore in the quarter ended on March 31, 2022.

The company had posted a net profit of Rs 519.59 crore for the corresponding period of the previous fiscal

All that happened in the markets today

The company reported a net profit of Rs 492.06 crore for the quarter

It said Divi's had made an announcement on July 10, 2017, during market hours that the US FDA would lift import alert 99-32 on the company's unit-II at Visakhapatnam

The second largest pharma player by market value is also expanding capacities to push earnings

Analysts at Motilal Oswal Securities expect Divi's earnings before interest, tax, depreciation and amortisation (Ebitda) margin to improve by 400 basis points to 36 per cent